Ted D. Kellner, Todd Deutsch, Robert L. Chioini and Paul W. Sweeney (the Kellner Group) have
filed a definitive proxy statement and accompanying GOLD proxy card with the Securities and Exchange Commission (SEC) to be used to solicit votes for their election to the Board of Directors of AIM Immunotech Inc., a Delaware
corporation (the Company or AIM), at the 2024 Annual Meeting of Stockholders scheduled to be held on December 17, 2024 (the Annual Meeting).
On December 2, 2024, the Kellner Group issued the press release that appears below and expects to distribute copies to stockholders by mail and
electronically:
Kellner Group Urges Stockholders of AIM Immunotech to Vote the Gold Card
Kellner Group Has Financial Resources AIM Needs
Kellner Group Owns 5.04% of Outstanding Shares and is Fully Aligned with Stockholders
AIM Cash Conservation Plan is Too Little Too Late, Exposes Desperate Financial Condition
AIM Stock Price has Declined 99+%
Frantic AIM Board Doubles Down on Attempts to Deceive Stockholders
New York, New York, December 2, 2024: Ted Kellner, as the nominating stockholder and a nominee, together with his other nominees, Todd Deutsch, Robert L.
Chioini and Paul W. Sweeney (collectively, the Kellner Group, we or us and, as nominees, the Kellner Group Nominees) today issue the following press release in connection with their efforts to bring
accountability to the entrenched, incumbent Board of Directors of AIM Immunotech Inc. (NYSE American: AIM).
Kellner Group Has Financial Resources
AIM Needs
Collectively, the Kellner Group Nominees have raised over $1.0 billion in investment capital in the past and have the networks and
resources to raise the significant capital that will be required for AIM.
|
|
|
Mr. Kellner has raised over $500 million in his career as equity capital for early-stage businesses,
management buyouts and real estate development projects. Fiduciary Management, the advisory firm he founded, currently manages over $16.0 billion in assets. His real estate development firm currently has $2.3 billion in assets.
|
|
|
|
Mr. Sweeney, with thirty-five years of private equity experience, has raised over $300 million in debt
and equity capital for buyout transactions and growth equity investments. These have included $5 million for an early-stage health care data analytics business, $20 million for an early-stage nuclear medicine company and approximately
$10 million for a start-up medical device manufacturer. |
|
|
|
Mr. Chioini, primarily while CEO of Rockwell Medical, raised over $250 million in capital, including
registered direct offerings, confidentially marketed public offerings, private placements, business development arrangements and other transactions. |
The Kellner Group has the resources and networks to successfully raise funds and provide the necessary runway to finally start creating value for
stockholders.
Given the tremendous damage that the incumbent Board has inflicted on AIMs financial condition, it will be imperative
for AIM to raise significant financing in a sustainable way. The incumbent Board simply does not have the credibility, skills, networks or resources to raise the capital that AIM needs. This has been proven over
the past almost nine years that the incumbent Board has been in control and failed.